Vaishnaw Akshay
CIK 0001458494
President of R&DDirector
Filings
19
Latest Apr 20, 2026
Issuers covered
3
Showing
19 of 19
Page 1
Track record
20 of 20 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 20 | 55% | +0.4% | +4.9% | +14.1% | -18.7% |
| 90 days | 19 | 84% | +3.0% | +4.3% | +13.0% | -15.5% |
| 180 days | 18 | 89% | +6.2% | +13.4% | +16.4% | -39.0% |
| 365 days | 18 | 56% | -8.3% | +21.3% | +26.9% | -67.2% |
Issuers
Companies where Vaishnaw Akshay has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 10 | Apr 20, 2026 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 6 | Aug 7, 2023 |
| EDIT | Editas Medicine, Inc. | 3 | Jun 3, 2024 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|